An Observational Study of Xeloda (Capecitabine) in Participants With Metastatic or Advanced Breast Cancer
Clinical trial NCT01725386 · COMPLETED
Trial details
- NCT number
- NCT01725386
- Sponsor
- Hoffmann-La Roche
- Status
- COMPLETED
- Study type
- OBSERVATIONAL
- Start date
- 2011-03-01
- Primary completion
- 2015-02-01
- Enrollment
- 274
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.